Page last updated: 2024-08-25

nedaplatin and paclitaxel

nedaplatin has been researched along with paclitaxel in 65 studies

Research

Studies (65)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (6.15)	18.2507
2000's	23 (35.38)	29.6817
2010's	30 (46.15)	24.3611
2020's	8 (12.31)	2.80

Authors

Authors	Studies
Ariyoshi, Y; Sugiura, T	1
Fukuda, S; Inuyama, Y; Satoh, N	1
Sugiyama, T; Ushijima, K; Yakushiji, M	1
Khattab, J; Urba, SG	1
Maekawa, R; Uchida, N; Yamada, H; Yoshioka, T	2
Fuwa, N	1
Kobayashi, H; Kubo, K; Okubo, Y; Takashi, S; Tsukadaira, A	1
Horiike, A; Kodama, T; Kunitoh, H; Nokihara, H; Ohe, Y; Saijo, N; Sekine, I; Tamura, T; Yamamoto, N	1
Demura, T; Harabayashi, T; Ishikawa, R; Koyanagi, T; Mitsuhashi, K; Murakumo, M; Seki, H; Shinohara, N; Suzuki, S; Toyota, H	1
Kamiura, S; Morishige, K; Ohta, Y; Saji, F; Yamamoto, T	1
Abe, Y; Aoki, M; Basaki, K; Hasegawa, Y; Kondo, H; Okudera, K; Okumura, K; Takahata, T; Takanashi, S; Tateishi, T; Yasui-Furukori, N	1
Ariyama, H; Baba, E; Harada, M; Kusaba, H; Mitsugi, K; Nakano, S; Qin, B; Shibata, Y; Takii, Y; Tanaka, R	1
Fujimoto, K; Hatayama, O; Kitaguchi, Y; Koizumi, T; Kubo, K; Sasabayashi, M; Wakamatsu, H; Yasuo, M; Yoshiike, F	1
Demura, T; Harabayashi, T; Matsuyama, H; Mitsuhashi, K; Murakumo, M; Nagamori, S; Nagao, K; Naito, K; Nonomura, K; Seki, H; Shinohara, N; Suzuki, S	1
Kawauchi, A; Mikami, K; Miki, T; Mizutani, Y; Nakamura, T; Nakanishi, H; Nomoto, T	1
Fukumori, T; Harada, A; Hayashi, H; Izaki, H; Kanayama, HO; Kishimoto, T; Nishitani, MA; Takahashi, M; Tanimoto, S; Taue, R; Yamamoto, Y	1
Fujisaka, Y; Ito, Y; Kato, T; Kunitoh, H; Nokihara, H; Ohe, Y; Sekine, I; Sumi, M; Tamura, T; Yamamoto, N	1
Jobo, T	1
Adachi, M; Ando, K; Hirose, T; Horichi, N; Ishida, H; Kusumoto, S; Ohmori, T; Ohnishi, T; Okuda, K; Shirai, T; Sugiyama, T	1
Inoue, H; Miki, T; Mizutani, Y; Nakayama, M; Nishimura, K; Nonomura, N; Oka, D; Okuyama, A	1
Chen, LK; Guan, ZZ; Hang, Y; Xu, GC; Yang, QY	1
Gong, Y; Hou, M; Huang, M; Lu, Y; Ren, L; Wang, J; Wei, Y; Zhou, L; Zhou, X; Zhu, J	1
Adachi, M; Hirose, T; Kusumoto, S; Nakashima, M; Ogura, K; Ohmori, T; Ohnishi, T; Okuda, K; Shirai, T; Sugiyama, T; Yamaoka, T	1
Cao, W; Geng, M; Jiang, J; Jin, Y; Li, H; Lou, G; Xi, W; Xu, C; Zhao, S	1
Kawauchi, A; Mikami, K; Miki, T; Nakamura, T; Shiraishi, T; Takaha, N	1
Ishiguro, K; Nishimura, M; Suda, T; Uchida, N	1
Liu, SP; Wang, XE; Zhang, MQ	1
Cai, YP; Lin, SJ; Xu, S	1
Huang, XE; Jiang, Y; Li, Y; Xiang, J; Yan, PW	1
Fukuta, F; Kitamura, H; Kunishima, Y; Masumori, N; Mutoh, M; Shigyo, M; Taguchi, K; Takahashi, A; Tanaka, T; Tsukamoto, T; Yanase, M	1
Chen, X; Li, H; Li, K; Li, X; Liu, Y; Lou, G; Yin, M; Zhang, H	1
Ota, T; Takeshima, N; Takizawa, K	1
Arakawa, A; Furukawa, N; Hirashima, Y; Itani, Y; Ito, K; Murakoshi, H; Tabata, T; Takekuma, M; Takeuchi, S; Tsubamoto, H	1
Duan, Z; Hu, P; Yue, Y; Zhou, X	1
Chen, XJ; Cheng, X; He, J; Li, QX; Shao, ZM; Shi, TY; Sun, MH; Wang, MY; Wei, Q; Wu, X; Yu, KD; Zhou, XY; Zhu, ML	1
Bian, X; Cheng, K; Guo, W; He, X; Huang, S; Jiang, X; Xu, J; Zhang, L	1
Chen, J; Fan, PS; He, YF; Hu, B; Hu, CL; Ji, CS; Jiang, FS; Wang, W; Yao, YW; Zhu, L	1
Cai, L; Li, CH; Li, DD; Liu, MY; Liu, W	1
Du, J; Hu, B; Hu, C; Wang, F; Zhang, Y	1
Kamata, S; Yoshinaga, A	1
Fujihara, A; Hongo, F; Kamoi, K; Miki, T; Nakamura, T; Nakanishi, H; Naya, Y; Oishi, M; Okihara, K; Ueda, T	1
Liang, H; Liu, E; Pan, F; Qin, H; Ruan, Z; Zhang, K	1
Chen, KN; Chen, Y; Fan, MY; Li, XT; Liang, Z; Sun, Y; Sun, YS; Wang, ZL; Wu, Y; Xiong, HC; Yan, WP; Zhang, XY	1
Fujisawa, M; Miyake, H; Nishikawa, M	1
Hu, T; Liu, H; Shi, Y; Song, SQ; Zhang, GN	1
Gridelli, C; Sacco, PC	1
Chen, KN; Chen, Y; Li, XT; Sun, YS; Wang, ZL	1
Fujii, N; Inoue, R; Kobayashi, K; Matsumoto, H; Matsuyama, H; Nagao, K; Shimizu, K; Yamamoto, Y	1
Gao, H; Han, Y; Yuan, L	1
Hou, J; Hu, Y; Li, F; Lu, Q; Wang, H; Wang, L; Xiang, W; Yu, X; Zeng, W; Zhang, Z	1
Hanai, K; Higure, T; Hoshi, A; Kawamura, Y; Nakajima, N; Nitta, M; Shimizu, Y; Terachi, T	1
Goto, Y; Hasegawa, Y; Hosomi, Y; Hotta, K; Inoue, A; Kishi, K; Kunitoh, H; Mori, K; Naito, Y; Nishio, M; Ohashi, Y; Tanai, C; Tomizawa, Y; Yamada, K; Yoh, K	1
Chen, J; Ding, Y; Ma, L; Zhang, L; Zhuang, Y	1
Ku, W; Lu, Z; Miao, Y; Palashati, H; Tan, Q; Xiong, H; Zhang, C	1
Liu, L; Liu, P; Lou, P; Lv, T; Ou, D; Qin, S; Wang, X; Wang, Y	1
Dong, Y; Grimm, R; Guo, J; Jiang, L; Kamel, IR; Li, H; Lu, Y; Qin, J; Qu, J; Wang, Z; Yan, X; Zhang, F; Zhang, H; Zhang, S; Zhang, T; Zhang, Z; Zhao, Y	1
Bi, J; Chen, S; Diao, C; Dong, Y; Fan, H; Fan, W; Feng, Q; Geng, D; Han, X; Huang, G; Li, F; Li, G; Li, P; Li, Q; Li, T; Li, W; Li, Y; Liu, B; Meng, M; Meng, Q; Ni, Y; Ren, H; Sheng, L; Sun, D; Sun, L; Sun, W; Sun, Y; Tian, H; Wang, C; Wang, J; Wei, Z; Xu, X; Xu, Y; Xue, G; Yang, X; Ye, X; Yu, G; Zhang, B; Zhang, K; Zhang, L; Zheng, A; Zou, Z	1
Liang, MR; Liu, H; Wang, YN; Zeng, SY; Zhong, ML	1
Chen, H; Hong, J; Li, C; Lu, Q; Shi, B	1
Chen, Z; Jiang, Y; Song, B	1
Li, Y; Wu, J; Zhu, G	1
Li, L; Song, C; Sun, Z; Wang, W; Xu, H; Yin, J	1
Hosomi, T; Makino, Y; Otsuka, H; Shibasaki, N; Shichiri, Y; Uketa, S	1
Bian, Z; Chang, J; Han, F; Liu, F; Lu, L; Yao, J	1

Reviews

6 review(s) available for nedaplatin and paclitaxel

Article	Year
[New promising anticancer drugs for lung cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:15 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Camptothecin; Clinical Trials as Topic; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Organoplatinum Compounds; Paclitaxel; Taxoids; Vinblastine; Vinorelbine	1994
[Head and neck cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:13 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Fluorouracil; Head and Neck Neoplasms; Humans; Organoplatinum Compounds; Paclitaxel; Taxoids	1997
[Promising new drugs for gynecological cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:13 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Clinical Trials, Phase I as Topic; Cyclophosphamide; Docetaxel; Drug Administration Schedule; Female; Genital Neoplasms, Female; Humans; Irinotecan; Organoplatinum Compounds; Paclitaxel; Taxoids; Topotecan	1997
Chemotherapy in head and neck cancer. Overview of newer agents. Hematology/oncology clinics of North America, 1999, Volume: 13, Issue:4 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Gemcitabine; Head and Neck Neoplasms; Humans; Organoplatinum Compounds; Paclitaxel; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Taxoids; Topotecan; Vinblastine; Vinorelbine	1999
[Current and future state of chemoradiotherapy for head and neck cancer]. Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 2002, Volume: 62, Issue:2 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Organoplatinum Compounds; Paclitaxel; Taxoids	2002
Novel cytotoxic drugs in advanced nonsmall cell lung cancer. Current opinion in oncology, 2016, Volume: 28, Issue:2 Topics: Albumins; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Humans; Lung Neoplasms; Organoplatinum Compounds; Paclitaxel; Taxoids; Treatment Outcome	2016

Trials

21 trial(s) available for nedaplatin and paclitaxel

Article	Year
Phase I study of cisplatin analogue nedaplatin (254-S) and paclitaxel in patients with unresectable squamous cell carcinoma. British journal of cancer, 2004, Mar-22, Volume: 90, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Organoplatinum Compounds; Paclitaxel; Treatment Outcome	2004
[Combination chemotherapy with nedaplatin and paclitaxel for ovarian cancer]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 10 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Gynecologic Surgical Procedures; Humans; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Thrombocytopenia; Treatment Outcome	2004
Weekly paclitaxel and nedaplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer: a phase I/II study. Japanese journal of clinical oncology, 2004, Volume: 34, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Paclitaxel; Radiotherapy Dosage; Survival Rate	2004
Phase I trial of nedaplatin and paclitaxel for patients with non-small cell lung cancer. Journal of chemotherapy (Florence, Italy), 2005, Volume: 17, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Organoplatinum Compounds; Paclitaxel	2005
Salvage chemotherapy with paclitaxel, ifosfamide, and nedaplatin in patients with urothelial cancer who had received prior cisplatin-based therapy. Cancer chemotherapy and pharmacology, 2006, Volume: 58, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Paclitaxel; Salvage Therapy; Treatment Outcome; Urologic Neoplasms	2006
Phase I study of cisplatin analogue nedaplatin, paclitaxel, and thoracic radiotherapy for unresectable stage III non-small cell lung cancer. Japanese journal of clinical oncology, 2007, Volume: 37, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Administration Schedule; Drug Tolerance; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Paclitaxel	2007
Phase I study of the combination of nedaplatin and weekly paclitaxel in patients with advanced non-small cell lung cancer. Cancer chemotherapy and pharmacology, 2008, Volume: 61, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Female; Fever; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Organoplatinum Compounds; Paclitaxel; Severity of Illness Index; Treatment Outcome	2008
Paclitaxel, ifosfamide, and nedaplatin (TIN) salvage chemotherapy for patients with advanced germ cell tumors. International journal of urology : official journal of the Japanese Urological Association, 2007, Volume: 14, Issue:6 Topics: Acute Kidney Injury; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Paclitaxel; Salvage Therapy; Testicular Neoplasms; Treatment Outcome	2007
[Nadaplatin or cisplatin combined with paclitaxol in treatment for non-small cell lung cancer: a randomized controlled study]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2007, Volume: 29, Issue:6 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Paclitaxel; Prospective Studies; Remission Induction; Survival Analysis; Thrombocytopenia; Treatment Outcome	2007
Phase II evaluation of nedaplatin and paclitaxel in patients with metastatic esophageal carcinoma. Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Prognosis; Survival Rate; Treatment Outcome	2009
Phase II study of the combination of nedaplatin and weekly paclitaxel in patients with advanced non-small cell lung cancer. Anticancer research, 2009, Volume: 29, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Paclitaxel	2009
A phase II study of paclitaxel and nedaplatin as first-line chemotherapy in patients with advanced esophageal cancer. Japanese journal of clinical oncology, 2009, Volume: 39, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Esophageal Neoplasms; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Organoplatinum Compounds; Paclitaxel; Prognosis; Survival Rate; Treatment Outcome	2009
Salvage chemotherapy with paclitaxel and gemcitabine plus nedaplatin (TGN) as part of multidisciplinary therapy in patients with heavily pretreated cisplatin-refractory germ cell tumors. International journal of clinical oncology, 2009, Volume: 14, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Catheter Ablation; Cisplatin; Deoxycytidine; Disease-Free Survival; Drug Resistance, Neoplasm; Gemcitabine; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Paclitaxel; Radiosurgery; Radiotherapy, Adjuvant; Salvage Therapy; Time Factors; Treatment Outcome; Young Adult	2009
Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study. International journal of radiation oncology, biology, physics, 2010, Nov-01, Volume: 78, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Leukopenia; Middle Aged; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Paclitaxel; Radiotherapy; Remission Induction; Uterine Cervical Neoplasms	2010
Efficacy and safety of endostar combined with chemotherapy in patients with advanced solid tumors. Asian Pacific journal of cancer prevention : APJCP, 2010, Volume: 11, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Deoxycytidine; Docetaxel; Endostatins; Female; Fluorouracil; Gemcitabine; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Neoplasms; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Recombinant Proteins; Survival Rate; Taxoids; Treatment Outcome	2010
Paclitaxel, ifosfamide, and nedaplatin as second-line treatment for patients with metastatic urothelial carcinoma: a phase II study of the SUOC group. Cancer science, 2011, Volume: 102, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Ifosfamide; Kidney Neoplasms; Kidney Pelvis; Male; Middle Aged; Organoplatinum Compounds; Paclitaxel; Treatment Outcome; Ureteral Neoplasms; Urinary Bladder Neoplasms	2011
Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: a Kansai Clinical Oncology Group study. Gynecologic oncology, 2012, Volume: 126, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Organoplatinum Compounds; Paclitaxel; Uterine Cervical Neoplasms	2012
A phase II study of paclitaxel and nedaplatin as front-line chemotherapy in Chinese patients with metastatic esophageal squamous cell carcinoma. World journal of gastroenterology, 2013, Sep-21, Volume: 19, Issue:35 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; China; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Middle Aged; Organoplatinum Compounds; Paclitaxel; Time Factors; Treatment Outcome	2013
Randomized control study of nedaplatin or cisplatin concomitant with other chemotherapy in the treatment of advanced non-small cell lung cancer. Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Case-Control Studies; Cisplatin; Deoxycytidine; Docetaxel; Female; Follow-Up Studies; Gemcitabine; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Pemetrexed; Prognosis; Retrospective Studies; Survival Rate; Taxoids; Vinblastine; Vinorelbine; Young Adult	2014
IMRT combined with S-1 concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a prospective phase II study. Investigational new drugs, 2019, Volume: 37, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Organoplatinum Compounds; Oxonic Acid; Paclitaxel; Prognosis; Prospective Studies; Radiotherapy, Intensity-Modulated; Survival Rate; Tegafur; Young Adult	2019
Microwave ablation plus chemotherapy versus chemotherapy in advanced non-small cell lung cancer: a multicenter, randomized, controlled, phase III clinical trial. European radiology, 2020, Volume: 30, Issue:5 Topics: Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Docetaxel; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Microwaves; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Paclitaxel; Pemetrexed; Progression-Free Survival; Prospective Studies; Radiofrequency Ablation; Treatment Outcome; Vinorelbine	2020

Other Studies

38 other study(ies) available for nedaplatin and paclitaxel

Article	Year
Sequence-dependent antitumor efficacy of combination chemotherapy with nedaplatin, a newly developed platinum, and paclitaxel. Cancer letters, 2001, Oct-22, Volume: 172, Issue:1 Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carboplatin; Carcinoma, Lewis Lung; Cisplatin; Female; Liver; Lung Neoplasms; Mice; Mice, Inbred C57BL; Organoplatinum Compounds; Paclitaxel; Time Factors	2001
Repeated arthralgia associated with granulocyte colony stimulating factor administration. Annals of the rheumatic diseases, 2002, Volume: 61, Issue:9 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Arthralgia; Carcinoma, Non-Small-Cell Lung; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Organoplatinum Compounds; Paclitaxel	2002
[Combination chemotherapy of paclitaxel followed by nedaplatin for human ovarian cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:11 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel	2002
[Paclitaxel, ifosfamide, nedaplatin (TIN) for patients with metastatic urothelial cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Organoplatinum Compounds; Paclitaxel; Survival Rate; Thrombocytopenia; Urologic Neoplasms	2004
In vitro sequence-dependent interaction between nedaplatin and paclitaxel in human cancer cell lines. Cancer chemotherapy and pharmacology, 2005, Volume: 56, Issue:3 Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Drug Combinations; Drug Interactions; Humans; Organoplatinum Compounds; Paclitaxel; Stomach Neoplasms	2005
[Salvage chemotherapy with paclitaxel, ifosphamide and nedaplatin for relapsed or refractory germ cell cancer]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2006, Volume: 97, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Resistance, Neoplasm; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Neutropenia; Organoplatinum Compounds; Paclitaxel; Salvage Therapy; Testicular Neoplasms; Thrombocytopenia	2006
[A non-seminomatous extra-gonadal germ cell tumor responding to intensive treatment: a case report]. Hinyokika kiyo. Acta urologica Japonica, 2006, Volume: 52, Issue:8 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Paclitaxel; Retroperitoneal Neoplasms	2006
[Outpatient chemotherapy in gynecologic oncology]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33 Suppl 2 Topics: Ambulatory Care Facilities; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Female; Humans; Irinotecan; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Uterine Cervical Neoplasms; Uterine Neoplasms	2006
[A case of aggressive primary squamous cell carcinoma of the breast refractory to preoperative neoadjuvant chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:13 Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Squamous Cell; Cyclophosphamide; Epirubicin; Fatal Outcome; Female; Fluorouracil; Humans; Lung Neoplasms; Neoadjuvant Therapy; Organoplatinum Compounds; Paclitaxel; Vinblastine; Vinorelbine	2009
[Comparison of outcomes of Taxol + Cisplatin and Taxol + Nedaplatin chemotherapy regimens for advanced non-small cell lung cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2010, Volume: 32, Issue:1 Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Remission Induction; Survival Rate; Taxoids; Young Adult	2010
The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer. Journal of surgical oncology, 2012, Volume: 105, Issue:2 Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Hysterectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome; Uterine Cervical Neoplasms	2012
Second-line chemotherapy for carboplatin/paclitaxel-refractory ovarian cancer: are multi-agent chemotherapies of little value truly? European journal of gynaecological oncology, 2011, Volume: 32, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Fallopian Tube Neoplasms; Female; Humans; Irinotecan; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Taxoids	2011
A case of occult bowel perforation after a cycle of chemotherapy for advanced epithelial ovarian carcinoma. European journal of gynaecological oncology, 2012, Volume: 33, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carcinoma, Ovarian Epithelial; Female; Humans; Intestinal Perforation; Neoadjuvant Therapy; Neoplasms, Glandular and Epithelial; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel	2012
Functional variants in TNFAIP8 associated with cervical cancer susceptibility and clinical outcomes. Carcinogenesis, 2013, Volume: 34, Issue:4 Topics: 3' Untranslated Regions; Apoptosis Regulatory Proteins; Case-Control Studies; Cell Line, Tumor; China; Cisplatin; Drug Resistance, Neoplasm; Female; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Humans; MicroRNAs; Organoplatinum Compounds; Paclitaxel; Polymorphism, Single Nucleotide; Risk; Uterine Cervical Neoplasms	2013
Concurrent chemoradiotherapy with nedaplatin plus paclitaxel or fluorouracil for locoregionally advanced nasopharyngeal carcinoma: Survival and toxicity. Head & neck, 2014, Volume: 36, Issue:10 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Disease Progression; Female; Fluorouracil; Humans; Male; Middle Aged; Multivariate Analysis; Nasopharyngeal Neoplasms; Organoplatinum Compounds; Paclitaxel; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated	2014
A retrospective study of paclitaxel combining nedaplatin chemotherapy for esophageal cancer. Anti-cancer drugs, 2015, Volume: 26, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Disease-Free Survival; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Organoplatinum Compounds; Paclitaxel; Retrospective Studies	2015
[Long survival in a patient with advanced ureteral carcinoma treated with TIN regimen (paclitaxel, ifosfamide, nedaplatin) and radiotherapy : a case report]. Hinyokika kiyo. Acta urologica Japonica, 2014, Volume: 60, Issue:9 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Humans; Ifosfamide; Male; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Time Factors; Tomography, X-Ray Computed; Ureteral Neoplasms	2014
Salvage combined chemotherapy with paclitaxel, ifosfamide and nedaplatin for patients with advanced germ cell tumors. International journal of urology : official journal of the Japanese Urological Association, 2015, Volume: 22, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Neoplasm; Humans; Ifosfamide; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Paclitaxel; Retrospective Studies; Salvage Therapy; Treatment Outcome; Young Adult	2015
Nedaplatin or oxaliplatin combined with paclitaxel and docetaxel as first-line treatment for patients with advanced non-small cell lung cancer. Medical science monitor : international medical journal of experimental and clinical research, 2014, Dec-30, Volume: 20 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Docetaxel; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Retrospective Studies; Taxoids	2014
CT Signs Can Predict Treatment Response and Long-Term Survival: A Study in Locally Advanced Esophageal Cancer with Preoperative Chemotherapy. Annals of surgical oncology, 2015, Volume: 22 Suppl 3 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Preoperative Care; Prognosis; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed	2015
Irinotecan and nedaplatin as salvage therapy for patients with advanced germ cell tumors following intensive treatment with cisplatin-based combination chemotherapies. International journal of clinical oncology, 2016, Volume: 21, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Camptothecin; Cisplatin; Etoposide; Humans; Ifosfamide; Irinotecan; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Paclitaxel; Retreatment; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Young Adult	2016
Addition of bevacizumab to neoadjuvant chemotherapy for Stage IV ovarian serous adenocarcinoma with multiple lymph node metastases: a case report. European journal of gynaecological oncology, 2015, Volume: 36, Issue:3 Topics: Adenocarcinoma; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Chemoradiotherapy, Adjuvant; Female; Humans; Lymph Nodes; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Cystic, Mucinous, and Serous; Organoplatinum Compounds; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Treatment Outcome	2015
Potential of Baseline Computed Tomography to Predict Long-Term Survival of Patients With Locally Advanced Esophageal Cancer Treated With Preoperative Chemotherapy: A Retrospective Cohort Study. Medicine, 2016, Volume: 95, Issue:18 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Retrospective Studies; Survival Rate; Time Factors; Tomography, X-Ray Computed; Tumor Burden	2016
Clinical significance of a second-line chemotherapy regimen with paclitaxel, ifosfamide and nedaplatin for metastatic urothelial carcinoma after failure of cisplatin-based chemotherapy. Japanese journal of clinical oncology, 2016, Volume: 46, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Creatinine; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Ifosfamide; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Paclitaxel; Prognosis; Retrospective Studies; Treatment Outcome; Urethral Neoplasms	2016
Comparisons of the survival time of patients with ovarian cancer adopting post-operative chemotherapy by use of paclitaxel combined with carboplatin or nedaplatin. World journal of surgical oncology, 2016, Jun-24, Volume: 14, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Papillary; Cystadenocarcinoma, Serous; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Postoperative Care; Prognosis; Survival Rate	2016
Value of intravoxel incoherent motion and dynamic contrast-enhanced MRI for predicting the early and short-term responses to chemoradiotherapy in nasopharyngeal carcinoma. Medicine, 2016, Volume: 95, Issue:35 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma; Chemoradiotherapy; Contrast Media; Diffusion Magnetic Resonance Imaging; Dose Fractionation, Radiation; Female; Gadolinium DTPA; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm, Residual; Organoplatinum Compounds; Paclitaxel; Perfusion; Predictive Value of Tests; ROC Curve; Time Factors; Treatment Outcome	2016
A Case of Mixed Germ Cell Tumor in the Intramedullary Spinal-cord. The Tokai journal of experimental and clinical medicine, 2016, Sep-20, Volume: 41, Issue:3 Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Bleomycin; Chorionic Gonadotropin; Cisplatin; Deoxycytidine; Etoposide; Gemcitabine; Guillain-Barre Syndrome; Humans; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Paclitaxel; Paraplegia; Spinal Cord Neoplasms; Tomography, X-Ray Computed	2016
Impact of Maintenance Therapy for Patients with Non-small Cell Lung Cancer in a Real-world Setting. Anticancer research, 2017, Volume: 37, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Organoplatinum Compounds; Paclitaxel; Pemetrexed; Prospective Studies; Research Design; Treatment Outcome	2017
A rare case report of ovarian juvenile granulosa cell tumor with massive ascites as the first sign, and review of literature: Case report and review of literature. Medicine, 2018, Volume: 97, Issue:25 Topics: Abdominal Cavity; Antineoplastic Agents; Ascites; CA-125 Antigen; Chemotherapy, Adjuvant; Female; Granulosa Cell Tumor; Humans; Neoplasm Staging; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Salpingo-oophorectomy; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography; Young Adult	2018
Immediate and substantial evolution of T-cell repertoire in peripheral blood and tumor microenvironment of patients with esophageal squamous cell carcinoma treated with preoperative chemotherapy. Carcinogenesis, 2018, 12-13, Volume: 39, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; Esophageal Squamous Cell Carcinoma; High-Throughput Nucleotide Sequencing; Humans; Immunotherapy; Lymphocytes, Tumor-Infiltrating; Organoplatinum Compounds; Paclitaxel; Receptors, Antigen, T-Cell; T-Lymphocytes; Tumor Microenvironment	2018
Accuracy of 3-T MRI for Preoperative T Staging of Esophageal Cancer After Neoadjuvant Chemotherapy, With Histopathologic Correlation. AJR. American journal of roentgenology, 2019, Volume: 212, Issue:4 Topics: Adult; Aged; Chemotherapy, Adjuvant; Contrast Media; Esophageal Neoplasms; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Prospective Studies	2019
Consolidation chemotherapy in early-stage cervical cancer patients with lymph node metastasis after radical hysterectomy. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2020, Volume: 30, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Consolidation Chemotherapy; Docetaxel; Female; Humans; Hysterectomy; Liposomes; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Retrospective Studies; Uterine Cervical Neoplasms	2020
Removal of tumor thrombus from the azygos vein in an esophageal squamous cell carcinoma patient. Journal of cardiothoracic surgery, 2020, Mar-26, Volume: 15, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Azygos Vein; Chemotherapy, Adjuvant; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Thrombosis	2020
Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer and Tumor Marker Analysis: Based on a Retrospective Analysis. Computational and mathematical methods in medicine, 2022, Volume: 2022 Topics: Abdominal Pain; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryonic Antigen; Case-Control Studies; Chemotherapy, Adjuvant; Cisplatin; Diarrhea; Exanthema; Female; Humans; Hyperglycemia; Irinotecan; Nausea; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Retrospective Studies; Uterine Cervical Neoplasms; Vomiting	2022
Efficacy Analysis of Comprehensive Nursing in the Care of Ovarian Carcinoma Treated with Paclitaxel Combined with Nedaplatin. Computational and mathematical methods in medicine, 2022, Volume: 2022 Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Nerve Growth Factor; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel	2022
Efficacy and Safety of the PD-1 Inhibitor Combined with Albumin-Bound Paclitaxel and Nedaplatin in Preoperative Neoadjuvant Therapy of Unresectable Stage III Lung Squamous Cell Carcinoma. Drug design, development and therapy, 2022, Volume: 16 Topics: Agranulocytosis; Albumin-Bound Paclitaxel; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Humans; Immune Checkpoint Inhibitors; Lung; Lung Neoplasms; Male; Neoadjuvant Therapy; Paclitaxel; Thrombocytopenia	2022
[Advanced Bladder Cancer with Multiple Pulmonary Metastases Treated with Paclitaxel/Ifosfamide/Nedaplatin Therapy : Two Case Reports]. Hinyokika kiyo. Acta urologica Japonica, 2023, Volume: 69, Issue:7 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Paclitaxel; Urinary Bladder Neoplasms	2023
Thyroid collision tumour with pulmonary metastases treated effectively with nedaplatin and paclitaxel chemotherapy: A case report. The Journal of international medical research, 2023, Volume: 51, Issue:11 Topics: Female; Humans; Lung Neoplasms; Middle Aged; Paclitaxel; Thyroid Neoplasms	2023

chemdatabank.com